Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nykode Therapeutics

Less than 1K followers

NYKD

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor views

Nykode Therapeutics is a biotechnology company. The company specializes in the research and development of immunological therapies and vaccines. The solutions are mainly used for the treatment of patients with cancer and other serious health conditions that require long-term treatment. The largest operations are in the European market.

Read more
Market cap
-
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
25/11
2026

Interim report Q3'26

24/2
2027

Annual report '26

All
Press releases
ShowingAll content types

Regulatory press release2026-09-09 14:59

NYKD: Nykode Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Nykode Therapeutics
Regulatory press release2026-08-31 15:26

Nykode Therapeutics ASA - New share capital registered

Nykode Therapeutics
Regulatory press release2026-08-31 11:35

NYKD: Mandatory notification of transaction

Nykode Therapeutics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-08-28 00:20

NYKD: Mandatory notification of trade

Nykode Therapeutics
Regulatory press release2026-08-27 23:51

Nykode Therapeutics ASA - Private Placement Completed

Nykode Therapeutics
Regulatory press release2026-08-27 16:32

Nykode Therapeutics ASA - Contemplated Private Placement

Nykode Therapeutics
Press release2026-08-27 14:54

Analyst Group: Analyst Group Interview Nykode Therapeutics' CEO Michael Engsig

Nykode Therapeutics
Regulatory press release2026-08-26 15:15

NYKD: Nykode Therapeutics receives draft recommendation from Secretariat of Tax Appeal Board in pending tax case

Nykode Therapeutics
Regulatory press release2026-08-26 07:00

Nykode Therapeutics - Quarterly Report Q2 2026

Nykode Therapeutics
Regulatory press release2026-08-21 19:19

Nykode Therapeutics - Invitation to Q2 2026 Financial Results Presentation

Nykode Therapeutics
Regulatory press release2026-08-20 15:22

NYKD: Nykode Therapeutics Receives New U.S. Patent Strengthening Intellectual Property Protection for its fully individualized VB10.NEO cancer vaccine program

Nykode Therapeutics
Regulatory press release2026-08-06 20:05

Nykode Therapeutics - Grant of share options

Nykode Therapeutics
Regulatory press release2026-08-04 22:15

Nykode Therapeutics - update on expected timeline for pending tax appeal

Nykode Therapeutics
Regulatory press release2026-07-22 14:00

NYKD: Nykode Therapeutics Presents Comprehensive Preclinical Data, Optimized Manufacturing, and Durable Clinical Immunogenicity for their Individualized Neoantigen Therapy VB10.NEO

Nykode Therapeutics
Regulatory press release2026-05-27 07:00

Nykode Therapeutics - Quarterly Report Q1 2026

Nykode Therapeutics
Regulatory press release2026-05-18 11:34

Nykode Therapeutics - Invitation to Q1 2026 Financial Results Presentation

Nykode Therapeutics
Regulatory press release2026-05-13 11:15

Nykode Therapeutics ASA - Minutes of Annual General Meeting

Nykode Therapeutics
Regulatory press release2026-05-07 13:54

NYKD: Nykode Therapeutics Doses First Patient in Abili-T Phase II Randomized Trial evaluating Abi-suva in HPV16-Positive, PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer Patients

Nykode Therapeutics
Regulatory press release2026-04-30 08:30

NYKD: Nykode Therapeutics Presents AI-Powered Immunotherapy Design Capabilities at BioPharma Drug Discovery Nexus 2026

Nykode Therapeutics
Regulatory press release2026-04-21 08:30

Nykode Therapeutics ASA - Notice of Annual General Meeting

Nykode Therapeutics